A pilot assessment of xanthine oxidase activity in plasma from patients with hematological malignancies using a highly sensitive assay.
Hokama N, Shirakura T, Sunagawa S, Morishima S, Nakachi S, Nishi Y, Murayama Y, Matsui C, Hase N, Tamura M, Okamoto S, Shimabukuro M, Nakamura K, Masuzaki H.
Hokama N, et al. Among authors: masuzaki h.
Hematol Oncol. 2019 Oct;37(4):527-530. doi: 10.1002/hon.2659. Epub 2019 Aug 27.
Hematol Oncol. 2019.
PMID: 31359444
Clinical Trial.
No abstract available.